20th International Congress » Ataxia
Date: Wednesday, June 22, 2016
Time: 12:00pm-1:30pm
Location: Exhibit Hall located in Hall B, Level 2
Session Type: Poster Session
Meeting: 20th International Congress
- 12:00pm-1:30pm
-
A cross-sectional study in spinocerebellar ataxia type 12 (SCA-12) patients from a tertiary care center in Eastern India
- 12:00pm-1:30pm
-
A largest case series study of spinocerebellar ataxia type 2(SCA2) from India: Do SCA2 clinical subtypes exists?
- 12:00pm-1:30pm
-
A unique phenotype associated with anti-GAD antibodies
- 12:00pm-1:30pm
-
Abnormal findings in polisomnographic records of patients with spinocerebellar ataxia type 2 (SCA2)
- 12:00pm-1:30pm
-
Acute cerebellar degeneration as the first manifestation of Sjögren syndrome: A case report
- 12:00pm-1:30pm
-
Autosomal recessive ataxia due to ANO10 mutations; full and novel phenotypic data in an Irish pedigree
- 12:00pm-1:30pm
-
Can quantitative analysis of the “finger-to-nose test” discern between EOA and other conditions of coordination impairment?
- 12:00pm-1:30pm
-
Cerebellar ataxia and pregnancy
- 12:00pm-1:30pm
-
Clinical and analytical validation of novel autosomal recessive ataxia mutations identified from whole exome sequencing
- 12:00pm-1:30pm
-
Clinical and imaging characteristics of spinocerebellar ataxia type 14 defined in a German multi-center sample
- 12:00pm-1:30pm
-
Comparison of mental practice and proprioceptive neuromuscular facilitation in sisters with cerebellar atrophy
- 12:00pm-1:30pm
-
Core set of measures of balance for people with multiple sclerosis and cerebellar ataxia
- 12:00pm-1:30pm
-
Deep brain stimulation of the dentate nucleus improves ataxia and modulates cortical excitability
- 12:00pm-1:30pm
-
Early clinical features of paraneoplastic cerebellar degeneration: Diagnostic outcomes of adult onset cerebellar ataxia
- 12:00pm-1:30pm
-
Esophageal involvement in multiple system atrophy
- 12:00pm-1:30pm
-
European pediatric normative values for the scale for assessment and rating of ataxia (SARA)
- 12:00pm-1:30pm
-
Evaluating the effects of deep brain stimulation (DBS) in mice with spinocerebellar ataxia (SCA1)
- 12:00pm-1:30pm
-
Evaluation of parkinsonism and striatal dopamine transporter loss in patients with spinocerebellar ataxia type 6
- 12:00pm-1:30pm
-
Fiberoptic endoscopic evaluation of swallowing findings in patients with Machado-Joseph disease
- 12:00pm-1:30pm
-
Iron accumulation and volume loss in the extrapyramidal motor system in Friedreich ataxia: The IMAGE-FRDA study
- 12:00pm-1:30pm
-
Long-term impact of lead poisoning on neurologic function in children and adolescents
- 12:00pm-1:30pm
-
Movement disorders are the common signs as the first neurological deficit in cases with spinocerebellar ataxia type 2 (SCA2)
- 12:00pm-1:30pm
-
Natural history of saccadic abnormalities in spinocerebellar ataxia 2: Implications to designing future clinical trials
- 12:00pm-1:30pm
-
Olfaction analysis in spinocerebellar ataxia type 10 and type 3 comparing with healthy controls and PD
- 12:00pm-1:30pm
-
Peripheral insulin sensitivity and body composition alterations in early stage Machado Joseph disease
- 12:00pm-1:30pm
-
Prodromal criteria of spinocerebellar type 2: Lessons for physiopathology, natural history and therapeutical trials
- 12:00pm-1:30pm
-
Prolonged cerebellar syndrome after Legionnaire’s disease
- 12:00pm-1:30pm
-
Psychogenic movement disorder in cerebellar atrophy
- 12:00pm-1:30pm
-
Repeat size and X-inactivation in the clinical phenotype of fragile X premutation carrier sisters: A familial case series
- 12:00pm-1:30pm
-
Spinocerebellar ataxia 17: First observation in Russia
- 12:00pm-1:30pm
-
Sporadic cerebellar ataxia associated with hypogonadotropic hypogonadism and PNPLA6 gene mutation. Case report in a Brazilian patient
- 12:00pm-1:30pm
-
STUB1/CHIP mutations cause Gordon Holmes syndrome as part of widespread multisystemic neurodegeneration: Evidence from novel mutations
- 12:00pm-1:30pm
-
Sub-acute rapidly progressive cerebellar ataxia – A case of JC virus associated granule cell neuronopathy (GCN)
- 12:00pm-1:30pm
-
Testing candidate transcriptional biomarkers of asymtpomatic and symptomatic stages in spinocerebellar ataxia type 3 (SCA3)
- 12:00pm-1:30pm
-
The aetiology of idiopathic late onset cerebellar ataxia